Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

The dark side of HDAC inhibition in ALS.

Boutillier AL, Tzeplaeff L, Dupuis L.

EBioMedicine. 2019 Feb 22. pii: S2352-3964(19)30117-3. doi: 10.1016/j.ebiom.2019.02.039. [Epub ahead of print] No abstract available.

2.

Reinstating plasticity and memory in a tauopathy mouse model with an acetyltransferase activator.

Chatterjee S, Cassel R, Schneider-Anthony A, Merienne K, Cosquer B, Tzeplaeff L, Halder Sinha S, Kumar M, Chaturbedy P, Eswaramoorthy M, Le Gras S, Keime C, Bousiges O, Dutar P, Petsophonsakul P, Rampon C, Cassel JC, Buée L, Blum D, Kundu TK, Boutillier AL.

EMBO Mol Med. 2018 Nov;10(11). pii: e8587. doi: 10.15252/emmm.201708587.

3.

Investigation of Anti-SOD1 Antibodies Yields New Structural Insight into SOD1 Misfolding and Surprising Behavior of the Antibodies Themselves.

Atlasi RS, Malik R, Corrales CI, Tzeplaeff L, Whitelegge JP, Cashman NR, Bitan G.

ACS Chem Biol. 2018 Sep 21;13(9):2794-2807. doi: 10.1021/acschembio.8b00729. Epub 2018 Aug 30.

Supplemental Content

Loading ...
Support Center